Bu içeriği görüntülemek için JoVE aboneliği gereklidir. Oturum açın veya ücretsiz deneme sürümünü başlatın.
Method Article
This protocol provides a simple and efficient way to propagate human pluripotent stem cells (hPSCs) using only conditioned media derived from the human placenta in a gelatin-coated dish without additional exogenous supplementation or hPSC-specific synthetic substrata.
The propagation of human pluripotent stem cells (hPSCs) in conditioned medium derived from human cells in feeder-free culture conditions has been of interest. Nevertheless, an ideal humanized ex vivo feeder-free propagation method for hPSCs has not been developed; currently, additional exogenous substrates including basic fibroblast growth factor (bFGF), a master hPSC-sustaining factor, is added to all of culture media and synthetic substrata such as Matrigel or laminin are used in all feeder-free cultures. Recently, our group developed a simple and efficient protocol for the propagation of hPSCs using only conditioned media derived from the human placenta on a gelatin-coated dish without additional exogenous supplementation or synthetic substrata specific to hPSCs. This protocol has not been reported previously and might enable researchers to propagate hPSCs efficiently in humanized culture conditions. Additionally, this model obviates hPSC contamination risks by animal products such as viruses or unknown proteins. Furthermore, this system facilitates easy mass production of hPSCs using the gelatin coating, which is simple to handle, dramatically decreases the overall costs of ex vivo hPSC maintenance.
The goal of this protocol is the propagation of human pluripotent stem cells (hPSCs) including human embryonic stem cells (hESCs) and human induced pluripotent stem cells (iPSCs) in fully humanized ex vivo feeder-free conditions without requiring additional exogenous supplementation and synthetic substrates. To date, the development of ex vivo hPSC culture models, that enable the introduction of culture products to the clinic, has been a major concern in stem cell research. Specifically, two critical problems need to be addressed. First, a humanized ex vivo culture system for the propagation of hPSCs that obviates the risk of contamination by animal cell products is needed. Second, a feeder-free culture model is needed to facilitate easy and economic mass production of hPSCs. For therapeutic applications of hPSCs, it is necessary to identify the factors that regulate their self-renewal and differentiation.
Since Xu et al. initially reported the feasibility of using conditioned media (CM) derived from mouse embryonic fibroblasts (MEF) to grow hESCs on Matrigel1, many studies have examined optimal ex vivo propagation methods for hPSCs2-4. However, an ideal humanized ex vivo feeder-free hPSC propagation system has not been developed because current methods require additional exogenous substrates including bFGF and insulin, well-known hPSC-sustaining factors, in culture media5-7. Moreover, synthetic substrata such as Matrigel or laminin are used in all feeder-free cultures.
The rationale behind the development and use of this protocol is based on our previous studies showing that human placenta chorion cells excellently support the propagation of hPSCs without bFGF supplementation8-11. This protocol has a number of advantages including its simplicity with respect to handling and its cost-effectiveness, and it is a near-perfect humanized culture that enables hPSC propagation without exogenous synthetic substrates. The application of human placenta-derived CM (hPCCM) for hPSCs involves 3 steps. First, chorion cells are isolated from the human placenta and cultured. Second, hPCCM is produced from cultured cells. Third, hPSCs are cultured using hPCCM and their characteristics are confirmed.
This protocol will facilitate clinical applications of hPSCs and studies of the mechanisms of hPSC proliferation and attachment. In this paper, the protocol for the successful propagation of hPSCs in hPCCM on a gelatin-coated dish is presented.
Access restricted. Please log in or start a trial to view this content.
Etik bildirimi: İnsan plasenta çalışması Kore Üniversitesi (AN09085-001) insan araştırma için Kurumsal Değerlendirme Kurulu onayı ile, ileriye dönük olarak. Tüm deneyler Kore Üniversitesi Tıp Merkezi'nde Temiz Germ-Alerjik Oda tesis yapıldı. deneysel tasarım ve hPSCs kullanarak prosedürleri Kore Üniversitesi Tıp Merkezi Kurumsal Değerlendirme Kurulu (AN12277-003) tarafından onaylanmıştır.
Araçların, Kültür Medya ve Yemekleri 1. Hazırlık
Insan plasentasından 2. Hücre İzolasyonu
3. Hasat İnsan Plasenta türetilmiş hücreler Orta (hPCCM) Klima
4. Kültür İnsan Embriyonik Kök Hücreleri (hESC) ve Pluripotent Kök Hücre İndüksiyon (iPSCs)
İnsan Pluripotent Kök Hücre 5. Karakterizasyonu
Not: alkalin fosfataz boyama, İmmünositokimya, kantitatif gerçek zamanlı PCR (qRT-PCR) ve western blotting gibi çeşitli yöntemler kullanılarak hPSCs karakterize eder.
Access restricted. Please log in or start a trial to view this content.
Bu hPSC yayılım yöntemin bir avantajı insan hücrelerinden salgılanan bileşenleri kullanmasıdır. Protokolde en çok ciritical aşama insan plasentası türetilen hücrelerin izolasyonu ve kültürü. Bu gerektirir ve HPC plaka villus kesin bir kısmından doğru diseksiyon. 1 insan plasenta kaynaklı hücre izolasyonu için prosedürü göstermektedir. Bu işlem, basit ve hücrelerin izolasyonu için uygun olan ve kolay 1 saat içerisinde gerçekleştirilebilir. Şekil 2...
Access restricted. Please log in or start a trial to view this content.
Bu model, örneğin bFGF veya insülin gibi eksojen rekombinant büyüme faktörlerinin ilavesi olmadan insanlaştınlmış besleyici içermeyen kültür koşullarında özelliklerini muhafaza eden bir insanlaştırılmış mikroçevresinin hPSCs manipülasyonu sağlarken başarıyla hPSCs yaymak için geliştirilmiştir. Ekzojen bFGF takviyesi yaygındır ve Matrigel veya laminin gibi alt tabakalarının uygulanması hPSCs 14 besleyici içermeyen kültür için gereklidir.
Bu pro...
Access restricted. Please log in or start a trial to view this content.
Yazarlar herhangi bir çıkar çatışmaları gösterir.
Yazarlar plasental doku sağlamak için Soon-Cheol Hong (MD, Ph.D., Doçent, Kadın Hastalıkları ve Doğum Anabilim Dalı, Medical College Kore Üniversitesi) teşekkür etmek istiyorum. Bu eser Kore Ulusal Araştırma Vakfı (UÇK), Kore Cumhuriyeti hibe (R1211902) tarafından kısmen desteklenmiştir.
Access restricted. Please log in or start a trial to view this content.
Name | Company | Catalog Number | Comments |
Mitomycin-C | Sigma-Aldrich Corporation | M4287 | 10 μg/ml |
Mycoplasma detection kit | TaKaRa Bio Inc. | #6601 | |
Matrigel | BD Biosciences | #354277 | |
mTeSR1 | STEMCELL Technologies Inc. | #05850 | |
Dispase | Worthington Biochemical Corporation | LS02100 | 1 mg/ml |
Gelatin | Sigma-Aldrich Corporation | G2500 | 0.10% |
BM-Cyclin | Roche | 799 050 | 10 μg/ml |
RNeasy mini kit | Qiagen | 74104 | |
Nano Drop Spectrophotometer | Thermo Fisher Scientific Inc | ||
iQ SYBR Green qPCR Master Mix | Bio-Rad Laboratories | #170-8882AP | |
ES Cell Characterization kit | Chemicon International, Inc., | SCR001 | |
Power cDNA Synthesis Kit | iNtRON Biotechnology | 25011 | |
QIAamp® DNA Micro kit | Qiagen | 56304 | |
AmpF/STR® Identifiler® PCR Amplification kit | Applied Biosystems Inc. | 4322288 | |
Applied Biosystems® 3130xl Genetic Analyzer | Applied Biosystems Inc. |
Access restricted. Please log in or start a trial to view this content.
Bu JoVE makalesinin metnini veya resimlerini yeniden kullanma izni talebi
Izin talebiThis article has been published
Video Coming Soon
JoVE Hakkında
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır